Evotec, MMV providing researchers compounds free of charge

Evotec AG (Xetra:EVT) will use its compound management services to support the Malaria and Pathogen Box initiatives from Medicines for Malaria Venture, through which the not-for-profit provides researchers molecules to study free of charge. The Malaria Box, which is already available, contains 400 molecules against blood stage Plasmodium falciparum. MMV is still selecting molecules for the similarly sized Pathogen Box for malaria and a range of neglected diseases. The group expects to make the Pathogen Box available starting in 4Q15. On its website, Evotec says its services include high throughput compound analysis, inert atmosphere and low temperature storage and processing, and worldwide delivery.

Under the MMV initiatives, researchers are expected to share their findings and data in a scientific publication or publicly accessible database within two years of generating data. The compounds are being acquired from a mix of commercial suppliers and MMV collaborators who synthesize molecules. As of Tuesday, more than 160 Malaria boxes have been sent to 27 countries. ...